Ionis Pharmaceuticals, Inc.
MODULATION OF PREKALLIKREIN (PKK) EXPRESSION
Last updated:
Abstract:
Disclosed herein are antisense compounds and methods for decreasing PKK mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate PKK-associated diseases, disorders, and conditions.
Status:
Application
Type:
Utility
Filling date:
2 Jul 2021
Issue date:
2 Jun 2022